{"schema_version":"secwatch.filing_event.v1","accession":"0001601485-24-000057","form_type":"8-K","ticker":"ELTX","cik":"0001601485","company_name":"Elicio Therapeutics, Inc.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.932611+00:00","generated_at":"2026-05-30T13:19:26.017933+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Elicio Therapeutics appoints CEO Robert Connelly as Principal Financial and Accounting Officer","bullets":["Robert Connelly, already CEO and President, appointed as Principal Accounting Officer and Principal Financial Officer effective Oct 15, 2024.","Connelly has nearly 40 years of life science leadership; previously CEO of Axcella Health, Pulmatrix, and Domantis (acquired by GSK).","No family relationships with other directors or executive officers; no reportable transactions under Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001601485-24-000057","json":"https://secwatch.observer/filing/0001601485-24-000057.json","markdown":"https://secwatch.observer/filing/0001601485-24-000057.md","text":"https://secwatch.observer/filing/0001601485-24-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000057/0001601485-24-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000057/angn-20241015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:19:26.017933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a8819dcc29","claim":"Robert Connelly was appointed as Principal Accounting Officer and Principal Financial Officer at Elicio Therapeutics, Inc..","evidence_excerpt":"On October 15, 2024 , Elicio Therapeutics, Inc. (the “Company”) appointed Robert Connelly as the Company’s Principal Accounting Officer and Principal Financial Officer effective October 15, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1601485/000160148524000057/0001601485-24-000057-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer and Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}